Anzeige
Meldung des Tages: Wenn Lieferketten brechen: Dieses Metall könnte zum nächsten Engpass werden

Galapagos News

Aktie
WKN:  A0EAT9 ISIN:  BE0003818359 US-Symbol:  GLPGF Branche:  Biotechnologie Land:  Belgien
26,16 €
-0,28 €
-1,06%
12:20:35 Uhr
Depot/Watchlist
Marktkapitalisierung *
1,83 Mrd. €
Streubesitz
42,53%
KGV
-21,92
Index-Zuordnung
-

Galapagos News

26.03.26 - GlobeNewswire
Galapagos Announces Nomination of Gino Santini to its Board of Directors
Subject to his election by shareholders, the Board intends to appoint Mr. Santini as Chair, succeeding Jérôme Contamine
26.03.26 - GlobeNewswire
Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders’ Meetings
Mechelen, Belgium; March 26, 2026, 21:01 CET; regulated information — Galapagos NV (Euronext & NASDAQ: GLPG) today published its annual report for the financial year 2025 and ...
23.03.26 - GlobeNewswire
Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
Galapagos intends to enter into a strategic collaboration with Gilead following Gilead's acquisition of Ouro Medicines New partnership structure would achieve meaningfully ...
17.03.26 - GlobeNewswire
Galapagos Receives Transparency Notification from Bank of America
Mechelen, Belgium ; March 117, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Bank of America.
10.03.26 - GlobeNewswire
Galapagos Receives Transparency Notifications from Bank of America  
Mechelen, Belgium ; March 10, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America.
06.03.26 - GlobeNewswire
Galapagos Creates New Subscription Right Plan
Mechelen, Belgium; March 6, 2026, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 1,750,000 ...
05.03.26 - GlobeNewswire
Galapagos Appoints Tania Philipp as Chief Human Resources Officer
Seasoned Life Sciences Executive Joins Galapagos with Strong Track Record in Change Management
04.03.26 - GlobeNewswire
Galapagos Receives Transparency Notifications from Bank of America
Mechelen, Belgium ; March 4, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America.
23.02.26 - GlobeNewswire
Galapagos Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Strategic reset positions Galapagos for long-term value creation Robust 2025 year-end cash and financial investments of €3.0 billion and ongoing collaboration with Gilead enable ...
19.02.26 - GlobeNewswire
Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors  
Dr. Fontoura brings extensive global leadership, clinical development, and operational experience to the Board Mechelen, Belgium; February 19, 2026, 22:01 CET — Galapagos NV ...
16.02.26 - GlobeNewswire
Galapagos Receives Transparency Notification from Bank of America
Mechelen, Belgium ; February 16, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Bank of America.
10.02.26 - GlobeNewswire
Galapagos Receives Transparency Notifications from Bank of America
Mechelen, Belgium ; February 10, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America.
05.01.26 - GlobeNewswire
Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities
Mechelen, Belgium ; January 5, 2026, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the works council consultation process regarding the wind-...
18.12.25 - GlobeNewswire
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus
GLPG3667 met primary endpoint in dermatomyositis study, demonstrating a statistically significant clinical benefit and meaningful improvements on secondary measures of ...
08.12.25 - GlobeNewswire
Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025
High complete response rates and minimal residual disease (MRD) negativity, with durable responses, in high-risk mantle cell lymphoma (MCL) with GLPG5101, a fresh, early ...
26.11.25 - GlobeNewswire
Galapagos Receives Transparency Notifications from Bank of America
Mechelen, Belgium ; November 26, 2025, 07:30 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America.
05.11.25 - GlobeNewswire
Galapagos Reports Nine Months 2025 Financial Results and Provides Business Update
Strategic review process concluded with intention to wind down cell therapy business, representing optimal capital allocation pathway to support a stronger and sustainable future ...
03.11.25 - GlobeNewswire
Galapagos to Present New Data from Cell Therapy Program at ASH 2025
Oral presentation of GLPG5101 data from the ATALANTA-1 study in patients with high-risk relapsed/refractory mantle cell lymphoma
30.10.25 - GlobeNewswire
Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development
New Directors bring strong financial leadership, capital allocation, and business development expertise to the Board Mechelen, Belgium; October 30, 2025, 21:01 CET — Galapagos ...
23.10.25 - GlobeNewswire
Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors
Mechelen, Belgium ; October 23, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present new in vitro pharmacological data from its ...

Newssuche

Videos

newspaper
23.03.26 +2,70%
Technical Trading: Gold Long nach Absturz
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »